Ruby Meredith, MD, PhD

Dr. Meredith is a Professor of Radiation Oncology at the University of Alabama at Birmingham and a Senior Scientist at the UAB Comprehensive Cancer Center. 

Among her honors are an Endowed Chair established in her name, Best Doctors Listings for more than ten years, and induction as a Fellow in the American College of Radiation Oncology and the American Society for Therapeutic Radiology and Oncology.  She served on the Advisory Panel for the National Biotracer Facility Project, as well as multiple other radionuclide related councils.

These include over fifteen years on the Medical Internal Radiation Dosimetry committee of the Society of Nuclear Medicine and Molecular Imaging (SNMMI).  Her basic science background has facilitated the development and realization of multiple clinical trials.  She has been involved in 50 clinical trials for targeted radionuclide therapy and has served as a Principal Investigator for Orano Med’s Phase 1 clinical trial of Intraperitoneal  ²¹²Pb-TCMC-trastuzumab for HER-2 expressing malignancy.